HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

Featuring perspectives from Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics:

Introduction: San Antonio Memories (0:00)

PI3K/AKT/PTEN Alterations and Therapies (7:18)

Capivasertib (20:22)

Gedatolisib (34:08)

Inavolisib (47:07)

New Agents and Ongoing Trials (52:34)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.